Cover Image

Author correction to "Coordinated regulation of BACH1 and mitochondrial metabolism through tumor targeted self-assembled nanoparticles for effective triple negative breast cancer combination therapy" [Acta Pharmaceutica Sinica B 12 (2022) 3934-3951]

Saved in:

Bibliographic Details
Main Authors:	Xuan Yang (Author), Yalong Wang (Author), Junke Zhao (Author), Hehui Rong (Author), Yujun Chen (Author), Mengting Xiong (Author), Xiaoxing Ye (Author), Shihui Yu (Author), Haiyan Hu (Author)
Format:	Book
Published:	Elsevier, 2023-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Coordinated regulation of BACH1 and mitochondrial metabolism through tumor-targeted self-assembled nanoparticles for effective triple negative breast cancer combination therapy
by: Xuan Yang, et al.
Published: (2022)

Author correction to 'Approved HIV reverse transcriptase inhibitors in the past decade' [Acta Pharmaceutica Sinica B 12 (2022) 1567-1590]
by: Guangdi Li, et al.
Published: (2023)

Author correction to "Identification of the dietary supplement capsaicin as an inhibitor of Lassa virus entry" [Acta Pharmaceutica Sinica B 10 (2020) 789-798]
by: Ke Tang, et al.
Published: (2024)

Author correction to "Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors" [Acta Pharmaceutica Sinica B 12 (2022) 4501-4518]
by: Yuling Mao, et al.
Published: (2024)

Author correction to 'Protective effects of VMY-2-95 on corticosterone-induced injuries in mice and cellular models' [Acta Pharmaceutica Sinica B 11 (2021) 1903-1913]
by: Ziru Yu, et al.
Published: (2023)

Author correction to "Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers" [Acta Pharmaceutica Sinica B 11 (2021) 355-372]
by: Tingting Jiang, et al.
Published: (2022)

Author correction to 'Protective effects of VMY-2-95 on corticosterone-induced injuries in mice and cellular models' [Acta Pharmaceutica Sinica B 11(2021) 1903-1913]
by: Ziru Yu, et al.
Published: (2023)

Author correction to 'Establishment of pseudovirus infection mouse models for in vivo pharmacodynamics evaluation of filovirus entry inhibitors' [Acta Pharmaceutica Sinica B 8 (2018) 200-208]
by: Qing Chen, et al.
Published: (2020)

Author correction to "Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles" [Acta Pharmaceutica Sinica B 12 (2022) 1523-1533]
by: Canhao Wu, et al.
Published: (2023)

Erratum to "Identification of anti-Mycobacterium tuberculosis agents targeting the interaction of bacterial division proteins FtsZ and SepFe" [Acta Pharmaceutica Sinica B 13 (2023) 2056-2070]
by: Hongjuan Zhang, et al.
Published: (2023)

Author correction to 'Mevalonate improves anti-PD-1/PD-L1 efficacy by stabilizing CD274 mRNA' [Acta Pharmaceutica Sinica B 13 (2023) 2585-2600]
by: Wenxin Zhang, et al.
Published: (2023)

Author correction to 'Discovery and identification of EIF2AK2 as a direct key target of berberine for anti-inflammatory effects' [Acta Pharmaceutica Sinica B 13 (2023) 2138-2151]
by: Wei Wei, et al.
Published: (2024)

Author correction to 'Multifunctional regulatory protein connective tissue growth factor (CTGF): A potential therapeutic target for diverse diseases' [Acta pharmaceutica sinica B 12 (2022) 1740-1760]
by: Minyang Fu, et al.
Published: (2022)

Author correction to 'Design, synthesis and biological evaluation of chalcone analogues with novel dual antioxidant mechanisms as potential anti-ischemic stroke agents' [Acta Pharmaceutica Sinica B 9 (2019) 335-350]
by: Jiabing Wang, et al.
Published: (2022)

Author correction to "A nanocleaner specifically penetrates the blood‒brain barrier at lesions to clean toxic proteins and regulate inflammation in Alzheimer's disease" [Acta Pharmaceutica Sinica B 12, (2021) 4032-4044]
by: Ting Lei, et al.
Published: (2022)

Author correction to 'Cardamonin from a medicinal herb protects against LPS-induced septic shock by suppressing NLRP3 inflammasome' [Acta Pharmaceutica Sinica B 9 (2019) 734-744]
by: Zhilei Wang, et al.
Published: (2020)

Author correction to 'Actively priming autophagic cell death with novel transferrin receptor-targeted nanomedicine for synergistic chemotherapy against breast cancer' [Acta Pharmaceutica Sinica B 2019; 9(5):1061-1077]
by: Dong Mei, et al.
Published: (2020)

Author correction to 'Ruscogenin alleviates LPS-triggered pulmonary endothelial barrier dysfunction through targeting NMMHC IIA to modulate TLR4 signaling' [Acta Pharmaceutica Sinica B 12 (2022) 1198-1212]
by: Yunhao Wu, et al.
Published: (2022)

Author correction to "YPD-30, a prodrug of YPD-29B, is an oral small-molecule inhibitor targeting PD-L1 for the treatment of human cancer" [Acta Pharmaceutica Sinica B 12 (2022) 2845-2858]
by: Fangfang Lai, et al.
Published: (2023)

Author correction to 'TMEM16A inhibits angiotensin II-induced basilar artery smooth muscle cell migration in a WNK1-dependent manner' [Acta Pharmaceutica Sinica B 11 (2021) 3994-4007]
by: Huaqing Zheng, et al.
Published: (2023)

Author correction to 'Ablation of Akt2 and AMPKα2 rescues high fat diet-induced obesity and hepatic steatosis through Parkin-mediated mitophagy' [Acta Pharmaceutica Sinica B 11 (2021) 3508-3526]
by: Shuyi Wang, et al.
Published: (2023)

Author correction to 'Bioengineered miR-124-3p prodrug selectively alters the proteome of human carcinoma cells to control multiple cellular components and lung metastasis in vivo' [Acta Pharmaceutica Sinica B 11 (2021) 3950-3965]
by: Linglong Deng, et al.
Published: (2023)

Author correction to "DNA damage repair promotion in colonic epithelial cells by andrographolide downregulated cGAS‒STING pathway activation and contributed to the relief of CPT-11-induced intestinal mucositis" [Acta Pharmaceutica Sinica B 12 (2022) 262-273]
by: Yuanyuan Wang, et al.
Published: (2023)

Author correction to 'Herbal formula BaWeiBaiDuSan alleviates polymicrobial sepsis-induced liver injury via increasing the gut microbiota Lactobacillus johnsonii and regulating macrophage anti-inflammatory activity in mice' [Acta Pharmaceutica Sinica B 13 (2023) 1164-1179]
by: Xiaoqing Fan, et al.
Published: (2023)

Bach
by: Williams, C. F. Abdy (Charles Francis Abdy), 1855-1923

Sebastian Bach
by: Poole, Reginald Lane, 1857-1939

Bach's World
by: Chiapusso, Jan
Published: (1969)

Changes to Dermatologica Sinica in 2013
by: Chia-Yu Chu, MD, PhD
Published: (2013)

Folia Pharmaceutica Universitatis Carolinae L/2019
by: Opletalová, Veronika
Published: (2022)

Acknowledgement to Reviewers of Scientia Pharmaceutica in 2017
by: Scientia Pharmaceutica Editorial Office
Published: (2018)

Johann Sebastian Bach
by: Peyser, Herbert F. (Herbert Francis), 1886-1953

Johann Sebastian Bach
by: Ziemssen, Ludwig, 1823-1895; Upton, George P. (George Putnam), 1834-1919 [Translator]

Actas
by: Federación Colombiana de Obstetricia y Ginecología
Published: (1957)

Integración internacional de la revista Ars Pharmaceutica
by: Rafael Ruiz-Pérez, et al.

Acknowledgement to Reviewers of <em>Scientia Pharmaceutica </em>in 2019
by: Scientia Pharmaceutica Editorial Office
Published: (2020)

Acknowledgement to Reviewers of <em>Scientia Pharmaceutica</em> in 2018
by: Scientia Pharmaceutica Editorial Office
Published: (2019)

Acknowledgment to Reviewers of <i>Scientia Pharmaceutica</i> in 2021
by: Scientia Pharmaceutica Editorial Office
Published: (2022)

Acknowledgment to the Reviewers of <i>Scientia Pharmaceutica</i> in 2022
by: Scientia Pharmaceutica Editorial Office
Published: (2023)

Acknowledgment to Reviewers of <i>Scientia Pharmaceutica</i> in 2020
by: Scientia Pharmaceutica Editorial Office
Published: (2021)

Ein stilles Credo J.S. Bachs
by: Overstolz, Christian
Published: (2018)